M. Goldinger

Clinical effects of monoclonal antibody 17-1A combined with granulocyte/macrophage-colony-stimulating factor and interleukin-2 for treatment of patients with advanced colorectal carcinoma

J. Fagerberg, J. Shetye, B. Nilsson, 1999, Cancer Immunology, Immunotherapy.